World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
72
Citations
31331
World Ranking
19753
National Ranking
666

Overview

Bernard Nordlinger is affiliated with Assistance Publique - Hôpitaux de Paris in France and has contributed extensively to the field of medicine, particularly within oncology, surgery, and hepatology. Their research spans multiple subfields including oncology, public health, environmental and occupational health, surgery, hepatology, and general health professions.

The scientist's primary research topics include colorectal cancer treatments and studies, hepatocellular carcinoma treatment and prognosis, global health and surgery, artificial intelligence in healthcare and education, colorectal cancer surgical treatments, colorectal and anal carcinomas, and pancreatic and hepatic oncology research.

Recent publications authored or co-authored by Bernard Nordlinger include the following:

  • "Pre- and Postoperative Capecitabine Without or With Oxaliplatin in Locally Advanced Rectal Cancer: PETACC 6 Trial by EORTC GITCG and ROG, AIO, AGITG, BGDO, and FFCD" (2020) published in Journal of Clinical Oncology
  • "Preoperative systemic chemotherapy alters the histopathological growth patterns of colorectal liver metastases" (2021) published in The Journal of Pathology Clinical Research
  • "Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019)" (2020) published in European Journal of Surgical Oncology
  • "Rapport 24-03. Systèmes d'IA générative en santé: enjeux et perspectives" (2024) published in Bulletin de l Académie Nationale de Médecine
  • "Chirurgie et intelligence artificielle: c'est pour bientôt?" (2021) published in Journal de Chirurgie Viscérale

Bernard Nordlinger frequently collaborates with several co-authors, among whom are Murielle Mauer, Hans-Joachim Schmoll, Alexander Stein, Eric Van Cutsem, and Timothy Price.

The scientist has published in a range of academic venues, including:

  • Journal of Clinical Oncology
  • The Journal of Pathology Clinical Research
  • European Journal of Surgical Oncology
  • Bulletin de l Académie Nationale de Médecine
  • Journal de Chirurgie Viscérale

Their body of work addresses complex issues in colorectal cancer treatments, liver metastases, and the emerging interface of artificial intelligence with surgical techniques and healthcare systems. This multidisciplinary approach encompasses both clinical oncology and broader public health challenges.

Best Publications

  • ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

    H J Schmoll;E Van Cutsem;A Stein;V Valentini

  • Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983) : long-term results of a randomised, controlled, phase 3 trial

    Bernard Nordlinger;Halfdan Sorbye;Bengt Glimelius;Graeme J Poston

  • Early colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    R. Labianca;B. Nordlinger;G. D. Beretta;S. Mosconi

  • Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    E. Van Cutsem;A. Cervantes;B. Nordlinger;D. Arnold

  • Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial.

    Arnaud D. Roth;Sabine Tejpar;Mauro Delorenzi;Pu Yan

  • Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

    Christoph Schuhmacher;Stephan Gretschel;Florian Lordick;Peter Reichardt

  • Preoperative radiotherapy as adjuvant treatment in rectal cancer. Final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC).

    André Gerard;Marc Buyse;Bernard Nordlinger;Jean Loygue

  • Towards a pan-European consensus on the treatment of patients with colorectal liver metastases

    Eric Van Cutsem;Bernard Nordlinger;Rene Adam;Claus-Henning Köhne

  • Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?

    Stéphane Benoist;Antoine Brouquet;Christophe Penna;Catherine Julié

  • Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group

    Udo Vanhoefer;Philippe Rougier;Hansjochen Wilke;Michel P. Ducreux

  • Multicenter randomized trial of adjuvant fluorouracil and folinic acid compared with surgery alone after resection of colorectal liver metastases: FFCD ACHBTH AURC 9002 trial.

    Guillaume Portier;Dominique Elias;Olivier Bouche;Philippe Rougier

  • Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial

    Theo Ruers;Frits Van Coevorden;Cornelis J. A. Punt;Jean-Pierre E. N. Pierie

  • Randomized phase III trial comparing biweekly infusional fluorouracil/leucovorin alone or with irinotecan in the adjuvant treatment of stage III colon cancer: PETACC-3.

    Eric Van Cutsem;Roberto Labianca;György Bodoky;Carlo Barone

  • Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment.

    E. Van Cutsem;B. Nordlinger;A. Cervantes

  • Radiofrequency ablation combined with systemic treatment versus systemic treatment alone in patients with non-resectable colorectal liver metastases: a randomized EORTC Intergroup phase II study (EORTC 40004)

    T. Ruers;C. Punt;F. Van Coevorden;J. P. E. N. Pierie

  • Primary colon cancer: ESMO Clinical Practice Guidelines for diagnosis, adjuvant treatment and follow-up

    R. Labianca;B. Nordlinger;G. D. Beretta;A. Brouquet

  • Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel

    B. Nordlinger;E. Van Cutsem;T. Gruenberger;Bengt Glimelius;Bengt Glimelius

  • Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

    Bernard Nordlinger;Eric Van Cutsem;Philippe Rougier;Claus Henning Köhne

  • OncoSurge: A Strategy for Improving Resectability With Curative Intent in Metastatic Colorectal Cancer

    Graeme J. Poston;René Adam;Steven Alberts;Steven Curley

  • 6010 POSTER DISCUSSION Radiofrequency Ablation Combined With Systemic Treatment Versus Systemic Treatment Alone in Patients With Non- Resectable Colorectal Liver Metastases: a Randomized EORTC Intergroup Phase II Study (EORTC 40004)

    T. Ruers;C. Punt;F. van Coevorden;J. Ledermann

Frequent Co-Authors

Bengt Glimelius
Bengt Glimelius Uppsala University
Roberto Labianca
Roberto Labianca Mario Negri Institute for Pharmacological Research
John R. Zalcberg
John R. Zalcberg Monash University
Peter M. Schlag
Peter M. Schlag Charité - University Medicine Berlin
Wolf O. Bechstein
Wolf O. Bechstein Goethe University Frankfurt
Daniel G. Haller
Daniel G. Haller University of Pennsylvania
Andrés Cervantes
Andrés Cervantes University of Valencia
Josep Tabernero
Josep Tabernero Vall d´Hebron Institute of Oncology
David Cunningham
David Cunningham Royal Marsden NHS Foundation Trust

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career in the USA offers more than just the traditional MD route. Many students consider entry-level nursing degrees as accessible options. If you’re seeking a fast track, entry level msn programs online are a great way for non-nurses to transition into advanced nursing roles efficiently.

For those interested in less competitive admissions, you may wonder whats the easiest nursing program to get into?. Several schools offer flexible acceptance criteria for aspiring nurses. Alternatively, those wanting a pathway without standardized entrance tests can look for an lpn program no entrance exam.

If you prefer a non-clinical healthcare role, consider medical billing and coding. Plenty of medical billing and coding schools online with financial aid can help you enter this growing field at your own pace.

These online programs open the door to rewarding healthcare careers without the long commitment and competitive admissions of traditional medicine.

Best Scientists Citing Bernard Nordlinger

Trending Scientists

Recently Published Articles